Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
CALL
MetLife
MET
$61.9B
| $33.7M | 0.01% |
479,500
+266,329
| +125% | +$19M |
|
|
WRK
752
DELISTED
WestRock Company
WRK
| $33.6M | 0.01% |
668,882
-9,868
| -1% | -$498K |
|
753
CALL
ON Semiconductor
ON
$31.8B
| $33.3M | 0.01% |
+486,500
| New | +$34.1M |
|
754
Celanese
CE
$4.9B
| $33.3M | 0.01% |
247,051
+48,567
| +24% | +$7.42M |
|
755
Factset
FDS
$9.36B
| $33.2M | 0.01% |
81,349
-48,082
| -37% | -$20.4M |
|
756
CALL
Saia
SAIA
$9.27B
| $33.2M | 0.01% |
+70,000
| New | +$32.6M |
|
757
Jacobs Solutions
J
$15.9B
| $33.2M | 0.01% |
286,988
-185,329
| -39% | -$21.7M |
|
758
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $33.1M | 0.01% |
374,201
+281,508
| +304% | +$25M |
|
759
CALL
Oracle
ORCL
$374B
| $33.1M | 0.01% |
234,400
+179,300
| +325% | +$22.3M |
|
760
Markel Group
MKL
$23.3B
| $32.9M | 0.01% |
20,898
-224
| -1% | -$348K |
|
761
Illumina
ILMN
$31B
| $32.9M | 0.01% |
315,068
-482,060
| -60% | -$54.1M |
|
762
Dell
DELL
$262B
| $32.9M | 0.01% |
238,440
-395,720
| -62% | -$53.1M |
|
763
CALL
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $32.6M | 0.01% |
+288,000
| New | +$30.3M |
|
764
CALL
Mercado Libre
MELI
$95.2B
| $32.5M | 0.01% |
19,800
+7,300
| +58% | +$11.5M |
|
765
Stride
LRN
$3.41B
| $32.5M | 0.01% |
460,748
-55,647
| -11% | -$3.71M |
|
766
CALL
Moderna
MRNA
$21.8B
| $32.4M | 0.01% |
272,700
+252,700
| +1,264% | +$32M |
|
767
Jack Henry & Associates
JKHY
$10.9B
| $32.4M | 0.01% |
195,037
-40,529
| -17% | -$6.73M |
|
768
CF Industries
CF
$19.2B
| $32.4M | 0.01% |
436,479
-21,567
| -5% | -$1.67M |
|
769
CALL
Cadence Design Systems
CDNS
$93.6B
| $32.3M | 0.01% |
+105,000
| New | +$31.1M |
|
770
Cheniere Energy
CQP
$31.9B
| $32.3M | 0.01% |
657,837
+368,039
| +127% | +$17.9M |
|
771
XPO
XPO
$23.5B
| $32.3M | 0.01% |
304,273
+46,758
| +18% | +$5.24M |
|
772
Seadrill
SDRL
$2.8B
| $32.3M | 0.01% |
627,103
-995,669
| -61% | -$50.4M |
|
773
Alnylam Pharmaceuticals
ALNY
$27.5B
| $31.9M | 0.01% |
131,265
-62,707
| -32% | -$9.9M |
|
774
NRG Energy
NRG
$28.3B
| $31.7M | 0.01% |
407,654
-223,997
| -35% | -$17.4M |
|
775
US Physical Therapy
USPH
$1.2B
| $31.7M | 0.01% |
343,427
+321,190
| +1,444% | +$32.5M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.